Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(69 sites)
United States
Research Site, Birmingham, Alabama Research Site, Atlanta, Georgia Research Site, Baltimore, Maryland Research Site, Grand Rapids, Michigan Research Site, St Louis, Missouri Research Site, Hackensack, New Jersey Research Site, New York, New York Research Site, Stony Brook, New York Research Site, Charlotte, North Carolina Research Site, Winston-Salem, North Carolina Research Site, Akron, Ohio Research Site, Cincinnati, Ohio Research Site, Columbia, South Carolina Research Site, Morgantown, West Virginia Canada
Research Site, Calgary, Alberta Research Site, Edmonton, Alberta Research Site, Vancouver, British Columbia Research Site, Montreal, Quebec Germany
Research Site, Heidelberg India
Research Site, Bhubaneswar Japan
Research Site, Bunkyō City Research Site, Kawasaki-shi Research Site, Matsumoto-shi Research Site, Nakagami-gun Research Site, Saitama-Shi Romania
Research Site, Cluj-Napoca Research Site, Târgu Mureş Spain
Research Site, Esplugues de Llobregat Ukraine
Research Site, Dnipropetrovsk Research Site, Kharkiv Region Research Site, Zaporizhzhia United Kingdom
Research Site, Manchester Research Site, Nottingham